PFG Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

PFG Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14,285	Closed	-$777K	–	324
2019 Q1	$777K	Buy	+14,285	New	+$981K	0.24%	132

Other funds holding BEAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PFG Advisors's BEAT Position: Q2 2019 in Review

PFG Advisors sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 14,285 shares — an estimated $777K sold.

PFG Advisors first reported a position in BEAT in Q1 2019 and held it in 1 quarter. The position peaked at $777K in Q1 2019. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

PFG Advisors reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
PFG Advisors sold 14,285 BioTelemetry, Inc. shares in Q2 2019, an estimated $777K.
PFG Advisors first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 1 quarter.
PFG Advisors's BioTelemetry, Inc. position peaked at $777K in Q1 2019.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on PFG Advisors's 13F filing for Q2 2019, filed 5 Aug 2019.